Description
Démonstration de l'efficacité du premier inhibiteur irréversible et sélectif de la 17beta-HSD1 pour le traitement des cancers du sein sensibles aux estrogènes
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02018-04-01$279,226
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-04-01(start date) | $279,226 | — | Démonstration de l'efficacité du premier inhibiteur irréversible et sélectif de la 17beta-HSD1 pour le traite… |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2026-2027-Q1-01224 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $642,600 | FY2027 |
| 236-2022-2023-Q3-00410 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $841,500 | FY2023 |
| 236-2017-2018-Q1-00738 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $363,376 | FY2018 |
| 236-2015-2016-Q4-00105 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $160,000 | FY2017 |
| 236-2015-2016-Q4-00200 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $99,958 | FY2016 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2017-2018-Q4-00478 · retrieved 2026-11-15.